Is Waystar Integrated With NextGen?

On interfaces that predate the current AI conversation, which is a point in its favour.

The core of any clearinghouse integration is the X12 transaction set: 837 claims out, 835 remittances back, 270 and 271 for eligibility, 276 and 277 for claim status, and 278 for authorization requests and responses. NextGen Enterprise practice management produces and consumes these through its billing and EDI configuration, and NextGen Connect, the interface engine formerly known as Mirth, handles routing where a practice has custom flows. Waystar sits on the other end of those transactions with connections to payers and to Medicare systems, and its channel page emphasises direct Medicare connectivity as part of the offer.

Layered on top are the newer modules: coverage detection that looks for insurance on accounts presenting as self pay, automated claim attachments, an authorization suite that Waystar says can verify, initiate, check status on and retrieve authorization details, and denial management with payer specific appeal forms. Some of these run entirely inside Waystar's cloud platform against data pulled from NextGen; others post results back into NextGen fields. Which is which for your configuration is the thing to confirm, because it determines whether staff work in one screen or two.

What this is not is a FHIR R4 or SMART App Launch integration into the clinical chart. NextGen documents those interfaces and they matter for clinical agents, but revenue cycle work runs on the practice management side. That is why a Waystar deployment does not normally require the NextGen API Developer Program at all, and why a group with NextGen Connect expertise in house will find this integration far easier than one without it.

The practical list, as described on Waystar's NextGen material in September 2026.

Waystar attaches numbers to some of this: 2.8 times more coverage found than other vendors, and a claim that more than 30 percent of patients presenting as self pay have coverage. These are vendor figures without a published methodology. Ask for the denominator and the sample before you put them in a business case. The denial rate benchmark and the days in A/R benchmark give you a neutral baseline to measure against.

The AI content of the offer is concentrated in the authorization and denial modules, and these are the ones most worth piloting on their own numbers. Read prior authorization automation and denial management for what a good pilot measures.

Less than a clinical integration, but not nothing, and the items are different.

• Business associate agreement. Waystar processes protected health information at volume. Confirm subcontractors, data centre locations and retention, and whether de identified claims data is used for benchmarking products.
• EDI enrolment. Every payer connection needs enrolment paperwork, and this, not the technology, is what makes clearinghouse migrations slow. Ask Waystar for a payer enrolment plan with dates against your top twenty payers by revenue.
• NextGen configuration ownership. Somebody has to own the practice management EDI setup and any NextGen Connect channels. If that is a consultant, name them in the project plan.
• Automation scope. For any step Waystar performs automatically, such as initiating an authorization or filing an appeal, agree who reviews it and how errors surface. Robotic process automation against payer portals is brittle when portals change; ask how failures are reported.
• CMS-0057 readiness. The CMS Interoperability and Prior Authorization rule moves payer authorization to FHIR APIs on a published timetable. Ask Waystar how its authorization suite will use the payer APIs rather than portal automation. Our CMS prior authorization rule page and the provider checklist cover the timeline.

The HIPAA and AI compliance page applies here too. Revenue cycle data is protected health information whether or not a clinical note is involved.

Pricing is the first. Waystar prices against claim and transaction volume and does not publish rates. Not published. Checked September 2026. Ask for a per transaction schedule by transaction type, the minimum monthly commitment, and what happens to the rate at renewal. Our Waystar pricing page covers what is knowable in advance.

Write back scope is the second. Waystar's material describes results, statuses and authorization details, but it does not publish a field level statement of what posts into NextGen versus what stays in Waystar's platform. For a front desk that already works in NextGen, an eligibility result that lives in another tab is a workflow tax. Get the posting behaviour demonstrated on your NextGen build.

Module maturity is the third. "Preferred partner" covers the whole Waystar catalogue, but the authorization automation and denial prediction modules are younger than the clearinghouse core. Ask for reference practices on NextGen using each specific module you are buying, not Waystar in general.

Portal automation is the fourth. Where a payer offers no electronic authorization transaction, Waystar, like every vendor in the category, falls back on automation against payer portals or on staff. Ask what proportion of your authorization volume, by payer, runs on real 278 transactions versus portal automation versus people. The prior authorization software comparison shows how the vendors differ on that mix.

• Which Waystar modules are included in the quote, and which are priced separately?
• What is the per transaction rate by type, the minimum commitment, and the renewal uplift cap?
• What posts back into NextGen automatically, field by field, for eligibility, claim status, remits and authorizations?
• What is the payer enrolment plan and timetable for our top payers?
• For authorizations, what proportion of our volume runs on electronic 278 transactions, portal automation and manual work?
• How will the authorization suite use payer FHIR APIs under CMS-0057, and by when?
• Who owns NextGen Connect and EDI configuration during implementation, and after?
• Can you name two NextGen practices in our specialty using the same modules, and may we call them?

The revenue cycle automation page sets out how to measure a pilot so that the answer at ninety days is a number rather than an impression.

A preferred partner designation tells you the integration works. It does not tell you whether Waystar's authorization and denial modules will outperform what your team does today, or whether a competing clearinghouse would price your volume lower on a NextGen build. NextGen has a commercial reason to steer you to Waystar, and Waystar has one to sell you the whole catalogue.

Our vendor selection engagement prices two or three clearinghouse and automation options against your actual transaction mix, checks write back behaviour on your NextGen configuration, and runs the references. If you already run Waystar and want to know whether the newer AI modules are worth adding, an AI readiness audit measures your current denial and authorization performance first so the vendor's numbers have something to be compared against. We take no commissions. Book a call.